Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#175 / 175 Total
RLAY - Relay Therapeutics Inc - Stock Price Chart
TickerRLAY [NASD, RUT]
CompanyRelay Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap554.95MEPS (ttm)-2.40
P/E-EPS this Y12.43%
Forward P/E-EPS next Y-3.98%
PEG-EPS past 5Y-23.05%
P/S55.44EPS next 5Y2.09%
P/B0.70EPS Q/Q32.14%
Dividend-Sales Q/Q-
Insider Own24.63%Inst Own80.06%
Insider Trans-2.55%Inst Trans2.28%
Short Float14.37%EarningsMay 05/a
Analyst Recom1.42Target Price17.40
Avg Volume2.27M52W Range1.77 - 10.72
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THOMAS J CATINAZZOOfficerApr 29 '25Proposed Sale3.233,55811,492Apr 29 04:01 PM
THOMAS J CATINAZZOOfficerApr 28 '25Proposed Sale3.179813,110Apr 28 04:02 PM
Patel SanjivPresident and CEOApr 23 '25Sale2.9761,422182,423821,667Apr 24 04:03 PM
Bergstrom Donald APresident, R&DMar 27 '25Sale2.849862,800615,052Mar 31 04:19 PM
Rahmer PeterSee remarksMar 27 '25Sale2.84247701402,184Mar 31 04:15 PM
110131415161718